secwatch.observer — SEC 8-K summary
======================================

Issuer:     ANAVEX LIFE SCIENCES CORP. (AVXL)
CIK:        0001314052
Form:       8-K
Filed at:   2026-02-25T23:59:59+00:00
Accession:  0001731122-26-000305
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Anavex appoints Dr. Axel Paeger to Board of Directors effective Feb 23, 2026
----------------------------------------------------------------------------

- Dr. Paeger appointed to fill a vacancy on the board, effective February 23, 2026.
- Board determined Paeger is independent under Exchange Act and Nasdaq rules.
- Paeger is CEO of AMEOS Group, Europe's leading healthcare provider with 85 hospitals and 19,300 employees.
- No arrangements or transactions requiring disclosure under Item 404(a) between Paeger and Anavex.
- Paeger brings 30+ years of healthcare leadership; compensation consistent with other non-employee directors.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1314052/000173112226000305/0001731122-26-000305-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1314052/000173112226000305/e7371_8-k.htm
  HTML page:      https://secwatch.observer/filing/0001731122-26-000305

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer